Skip to main content
SpringerLink
Log in

Is earlier better for melanoma checkpoint blockade?

  • Perspective
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

A neoadjuvant approach relying on the administration of combined anti-CTLA-4–anti-PD-1 treatment before lymph node surgery is evaluated in two phase 1 trials. Encouraging clinical, pathological and immunological responses to neoadjuvant therapy were observed, suggesting that this concept warrants further exploration; however, any future approach must address the unacceptably high toxicity of the regimens evaluated in these trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Rationale for using neoadjuvant versus adjuvant immunotherapy in metastatic melanoma.

Similar content being viewed by others

References

  1. Robert, C. et al. N. Engl. J. Med. 372, 30–39 (2015).

    Article  Google Scholar 

  2. Robert, C. et al. N. Engl. J. Med. 372, 2521–2532 (2015).

    Article  CAS  Google Scholar 

  3. Robert, C. et al. N. Engl. J. Med. 372, 320–330 (2015).

    Article  CAS  Google Scholar 

  4. Robert, C. et al. J. Clin. Oncol. 36, 1668–1674 (2018).

    Article  CAS  Google Scholar 

  5. Wolchok, J. D. et al. N. Engl. J. Med. 369, 122–133 (2013).

    Article  CAS  Google Scholar 

  6. Eggermont, A. M. M. et al. N. Engl. J. Med. 378, 1789–1801 (2018).

    Article  CAS  Google Scholar 

  7. Weber, J. et al. N. Engl. J. Med. 377, 1824–1835 (2017).

    Article  CAS  Google Scholar 

  8. Amaria, R. N. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0197-1 (2018).

    Article  CAS  Google Scholar 

  9. Blank, C. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0198-0 (2018).

    Article  CAS  Google Scholar 

  10. Chen, Y. et al. Medicine (Baltimore) 97, e10634 (2018).

  11. MacLean, M. et al. Oncotarget 9, 24470–24479 (2018).

    Article  Google Scholar 

  12. Wolchok, J. D. et al. Clin. Cancer Res. 15, 7412–7420 (2009).

    Article  CAS  Google Scholar 

  13. Hodi, F. S. et al. J. Clin. Oncol. 34, 1510–1517 (2016).

    Article  CAS  Google Scholar 

  14. Liu, J. et al. Cancer Discov. 6, 1382–1399 (2016).

    Article  CAS  Google Scholar 

  15. Tetzlaff, M. T. et al. Ann. Oncol. 29, 1861–1868 (2018).

    Article  CAS  Google Scholar 

  16. Hellmann, M. D. et al. N. Engl. J. Med. 378, 2093–2104 (2018).

    Article  CAS  Google Scholar 

  17. Rizvi, N. A. et al. Science 348, 124–128 (2015).

    Article  CAS  Google Scholar 

  18. Long, G. V. et al. N. Engl. J. Med. 377, 1813–1823 (2017).

    Article  CAS  Google Scholar 

  19. Amaria, R. N. et al. Lancet Oncol. 19, 181–193 (2018).

    Article  CAS  Google Scholar 

  20. Gershenwald J. E. et al. CA Cancer J. Clin. 67, 472–492 (2017).

  21. Morton, D. L. et al. N. Engl. J. Med. 370, 599–609 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paris-Sud University, Kremlin-Bicêtre, France

    Caroline Robert

  2. Oncology Department and INSERM U981, Villejuf, France

    Caroline Robert

Authors
  1. Caroline Robert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline Robert.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Robert, C. Is earlier better for melanoma checkpoint blockade?. Nat Med 24, 1645–1648 (2018). https://doi.org/10.1038/s41591-018-0250-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-018-0250-0

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation